Magda is an experienced lawyer focused on corporate and transactional services for public companies in areas such as compliance with disclosure obligations and administrative and criminal proceedings regarding the Market Abuse Regulation.
Also advises on regulatory issues and ESG-compliant corporate governance.
Magda joined the GESSEL team in 2012 and became managing associate in 2019.
She mainly advises on public issues of shares and bonds, in particular working on drafting prospectuses and reviewing and negotiating agreements accompanying public offerings. She also focuses on advice related to compliance with disclosure obligations, in particular advising during administrative and criminal proceedings regarding MAR. In addition, Magda advises companies in their day-to-day operations on corporate and regulatory issues, in particular implementation of ESG-compliant corporate governance principles.
In addition to her strictly professional activities, Magda shares her experience with students at the Capital Markets Society of Warsaw University and conducts training events. She contributes to reviews of legislative initiatives, such as the consultations initiated by ESMA (European Securities and Markets Authority) on the revision of the MAR Regulation.
Securities issues and transactions:
- Cavatina Holding S.A. bond issue program (public offering) with a value of up to PLN 200 mln
- Accelerated book building – shares in Pure Biologics S.A. worth PLN 30 mln
- Public offering and transfer of listing from the alternative trading system to the main floor of the Warsaw Stock Exchange of Bioceltix S.A. worth PLN 4.2 mln
- IPO of Komex S.A. (transaction suspended)
- Transfer of listing from ATS to WSE Caspar Asset Management S.A. IPO Expertsender S.A. (transaction suspended)
- IPO of Cavatina Holding S.A. worth PLN 187.5 mln IPO of Bio Planet S.A. worth PLN 10 mln. Vercom S.A. IPO worth PLN 225 mln.
- Public offering and transfer of listing from the alternative trading system to the main floor of the Warsaw Stock Exchange of Pure Biologics S.A. worth PLN 54 mln
- SOP Polwax S.A. with a value of more than PLN 20 mln
- Bond issue program (public offering) of Benefit Systems S.A. with a value of up to PLN 100 mln
- Accelerated book building – shares held by Enterprise Investors in X-Trade Brokers Dom Maklerski S.A. worth PLN 111.2 mln
- IPO of Data Walk IPO worth PLN 10 mln
- IPO of 1C Entertainment S.A. (transaction cancelled) R22 IPO worth PLN 91 mln
- Exact Systems S.A. IPO. (transaction cancelled)
- Public offering and transfer of listing from the alternative trading system to the main floor of the Warsaw Stock Exchange Tower of Investments S.A. worth PLN 54 mln
- IPO of Danwood Holding S.A. (transaction cancelled) IPO of PBKM S.A. worth PLN 54.4 mln
- Transfer of listing from the alternative trading system to the main floor of the Warsaw Stock Exchange of Energia S.A.
- IPO of Sortras S.A. (transaction cancelled)
- Polimex Mostostal’s SPO worth PLN 114.5 mln Polwax S.A.’s IPO worth PLN 57.3 mln
- SOP Harper Hygienics S.A. (transaction cancelled) IPO Skarbiec Holding S.A. with a value of PLN 44.3 mln IPO Vigo System S.A. with a value of PLN 53 mln
- Issue of WB Electronics S.A. bonds worth PLN 180 mln
Market Abuse Regulation, disclosure obligations:
- Magda has conducted training and provided current advice on proper fulfilment of information obligations in transactions for: ABC Data S.A., Aegon PTE S.A., Alta S.A., Awbud S.A., Bio Planet S.A., Bioton S.A., BOŚ S.A., Cavatina Holding S.A., CD Projekt S.A.,
Comperia S.A., DataWalk S.A., Dom Maklerski BOŚ S.A., Enterprise Investors, Erbud S.A., Gino Rossi S.A., Harper Hygienics S.A., Impel S.A., Kredyt Inkaso S.A., Larq S.A., Lentex S.A., mBank S.A., Magellan S.A., Medicalgorythmics S.A., Mennica Polska S.A., Miri Capital Management LLC, Murapol S.A., Nestmedic S.A., Nextbike S.A., Novita S.A., Onde S.A., Pekaes S.A., Polimex Mostostal S.A., Polnord S.A. Protektor S.A., Pure Biologics S.A., R22 S.A., Skarbiec Holding S.A., Tesgas S.A., Vercom S.A., Workservice S.A., XTPL S.A.
- In addition, Magda represents companies and individuals in administrative and criminal proceedings concerning market abuse and due compliance with disclosure obligations.
- Advised on own shares buybacks of Decora S.A., Erbud S.A., and Onde S.A.
- Advised on the merging of Polimex Mostostal S.A. shares worth PLN 173.2 mln
- Advised on formulation of compensation policies for senior executives of banks and investment societies
- Advises on preparation and implementation of whistleblower procedures, related party transaction procedures, and remuneration policies as required by the legislative Act regarding public offering of securities
We advised the WSE-listed company Creotech Instruments S.A.
We advised the WSE-listed company Creotech Instruments S.A. on a non-brokered public offering conducted under an accelerated bookbuilding procedure worth approximately P...
We advised WSE-listed Pure Biologics S.A. on a PLN 12 million financing transaction
We advised WSE-listed Pure Biologics S.A. in a transaction to raise PLN 12 million in financing from a new investor, ACRX Investments Ltd. The transaction was executed ...
GESSEL advises Pure Biologics S.A., a company listed on the Warsaw Stock Exchange
GESSEL supported Pure Biologics S.A. and its shareholders in preparation of a prospect-less public share offering via the accelerated book building process and execution...
GESSEL advises Cavatina Holding S.A. on another public bond placement valued at PLN 16.5 mln
Cavatina Holding S.A. is continuing its planned sequence of bond offerings, bringing to the market P2022D series bonds with a value of PLN 16.5 mln – which, in conjuncti...
Education and achievements
- Legal studies at the Faculty of Law and Administration of the University of Warsaw
- Completed courses
investment advisor preparation course
organized by the Warsaw Chamber of Brokers and Advisers (2008)